Detection of stanozolol and its metabolites in equine urine by liquid chromatography-electrospray ionization ion trap mass spectrometry.

The research investigates how the synthetic anabolic steroid stanozolol is metabolized in a horse, as well as devising a procedure for detecting stanozolol and its byproducts in horse urine using liquid chromatography.

Objective and Methodology

• The primary focus of this research aimed to understand the metabolic processes (both Phase I and Phase II) involving stanozolol, an artificial anabolic steroid, once it has been administered via intramuscular injections to a thoroughbred gelding.
• Furthermore, the researchers worked on developing an analytical process capable of detecting stanozolol and its metabolites in equine urine.
• To complete this task, they utilized a series of techniques including solid phase extraction, acid solvolysis of Phase II conjugates, and analysis through positive ion electrospray ionization ion trap liquid chromatography-mass spectrometry (LC-MS).

Findings

• The main Phase I metabolic transformations of stanozolol included hydroxylation at C16 and at one other site. Hydroxylation is a chemical process commonly involved in the metabolism of various substances, including drugs such as stanozolol.
• Phase II metabolism was more extensive, involving the conjugation of stanozolol metabolites with sulfate and beta-glucuronide (a type of sugar molecule), effectively increasing their solubility and facilitating their excretion via urine.

Significance and Applications

• The research outcomes have significant implications for equine sports, particularly racing, where the use of synthetic anabolic steroids like stanozolol is common yet illicit.
• Through the development of a procedure for detecting stanozolol in horse urine, authorities can more effectively monitor and impose regulations against doping in horse racing. This boosts the integrity of equine sports and ensures a fair competitive environment.
• Additionally, understanding the metabolic pathways of stanozolol provides insights into the biological impacts of synthetic anabolic steroids on horses, which may contribute valuable information for equine health research in the future.